Skip to content

Cigna CI Other intangible assets—net

Other intangible assets—net at other companies

CVS Health logo
CVS HealthCVS
$25.07B-5.6%
UnitedHealth Group logo
UnitedHealth GroupUNH
$20.09B-12.4%
Elevance Health logo
Elevance HealthELV
$11.09B-7.1%
Cencora logo
CencoraCOR
$6.05B+56.7%
Humana logo
HumanaHUM
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG

Other financials

Income statement

See full
Revenue$68.5B+4.6%
Gross profit$14.4B-15.8%
Operating income$2.4B+19.6%
Net income$1.7B+25.0%
EPS (diluted)$6.26+29.1%

Balance sheet

See full
Cash & equivalents$7.0B-15.5%
Total debt$111.0M+32.1%
Total equity$42.2B+4.9%
Total assets$153.27B+1.7%

Cash flow

See full
Operating cash flow$1.1B-41.1%

Valuation

See full
Market cap$73.88B-21.1%
P/E11.9×-6.9×
P/S0.3×-0.1×

Profitability

See full
Gross margin20.6%-5.2pp
Operating margin3.4%-0.1pp
Net margin2.2%+0.3pp
FCF margin5.5%

Returns & leverage

See full
Return on equity15%+2.8pp
Debt / equity0.0×
Current ratio0.8×0.0×

Where this comes from

Reported directly by Cigna in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Cigna’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cigna's other intangible assets—net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cigna's other intangible assets—net?
Cigna (CI) reported other intangible assets—net of $27.32B in Q1 2026.
How has Cigna's other intangible assets—net changed year-over-year?
Cigna's other intangible assets—net decreased by 5.9% year-over-year, from $29.05B to $27.32B.
What is the long-term trend for Cigna's other intangible assets—net?
Over 5 years (2020 to 2025), Cigna's other intangible assets—net has grown at a -4.1% compound annual growth rate (CAGR), from $35.18B to $28.56B.
What does other intangible assets—net mean?
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.